← Back to All Filings

Moderna CFO James Mock Exercises Options & Sells $4.69M in Common Stock Under Rule 10b5-1

Medium SignificanceSeptember 14, 2026 at 4:39:11 PM EDT

Moderna, Inc.

$MRNA4CIK: 0001682852

Subscribe to track MRNA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Moderna, Inc. ($MRNA) - Form 4 Filing Summary • Insider: James M. Mock (Chief Financial Officer) • Transaction Date: September 10, 2026 • Transaction Type: Option Exercise & Sale (Rule 10b5-1 Plan) • Shares Sold: 34,836 shares @ $134.49 • Total Realized Value: $4,685,093.64 • Options Exercised: 19,836 shares @ $30.96 ($614,122.56) • Ending Direct Ownership: 59,375 shares

Comprehensive Analysis

Insider Transaction Overview

On September 14, 2026, Moderna, Inc. ($MRNA) Chief Financial Officer James M. Mock reported the exercise of stock options and subsequent sale of shares executed on September 10, 2026.

Key Details:

  • Option Exercise: Exercised 19,836 stock options with an exercise price of $30.96 per share.
  • Open Market Sales: Sold a total of 34,836 shares of Common Stock at an average price of $134.49 per share across two tranches (19,836 shares and 15,000 shares).
  • Total Gross Value: ~$4.69 million ($4,685,093.64).
  • Post-Transaction Holdings: Direct beneficial ownership stands at 59,375 common shares, plus 43,642 remaining derivative option contracts.
  • Pre-Scheduled Trading Plan: The transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan established on June 9, 2026.

Significance:

Because the transactions were conducted under a pre-established Rule 10b5-1 trading plan following option vesting, this activity reflects planned executive equity monetization rather than an ad-hoc or sentiment-driven open market trade.

Topics:#MRNA#Moderna#InsiderTrading#Form4#Biotech#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.